INSULIN RESISTANCE--AN UNDERLYING MECHANISM FOR LOW HDL CHOLESTEROL
INSULIN RESISTANCE--AN UNDERLYING MECHANISM FOR LOW HDL CHOLESTEROL
批准号:
3742835
负责人:
ABHIMANYU GARG
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This proposal will test the hypothesis that insulin resistance, present
universally in NIDDM patients and in up to 25% of subjects with normal
glucose tolerance, may be the underlying metabolic defect resulting in
low HDL levels. Reduced responsiveness of adipose tissue lipoprotein
lipase to insulin and increased catabolic rate of apolipoprotein A-1 may
explain low HDL-cholesterol levels in NIDDM patients and insulin
resistant subjects.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PHYSICAL AND METABOLIC ABNORMALITIES OF LIPODYSTROPHY
-
批准号:3742830
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:ABHIMANYU GARG
-
依托单位:
SITOSTANOL THERAPY FOR HYPERLIPIDEMIC INSULIN DEPENDENT DIABETES
-
批准号:3742847
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:ABHIMANYU GARG
-
依托单位:
GLUCOSE AND LIPID METABOLISM IN GLIPIZIDE TREATED NIDDM PATIENTS
-
批准号:3742785
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:ABHIMANYU GARG
-
依托单位:
CHOLESTYRAMINE FOR DYSLIPIDEMIA IN NONINSULIN DEPENDENT DIABETICS
-
批准号:3742793
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:ABHIMANYU GARG
-
依托单位:
HETEROGENEITY OF APO B LIPOPROTEINS IN IDDM
-
批准号:3742812
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:ABHIMANYU GARG
-
依托单位:
SKELETAL MUSCLE MORPHOLOGY AND EXERCISE RESPONSE IN LIPODYSTROPHY
-
批准号:3742780
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:ABHIMANYU GARG
-
依托单位:
EFFECT OF INSULIN ON IN VITRO ADIPOCYTE LIPOLYSIS
-
批准号:3742800
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:ABHIMANYU GARG
-
依托单位:
EFFECT OF DIETARY FIBER IN PATIENTS WITH NIDDM
-
批准号:3742825
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:ABHIMANYU GARG
-
依托单位:
GLUCOSE METABOLISM AND INSULIN RESISTANCE IN ASIAN INDIANS
-
批准号:3742849
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:ABHIMANYU GARG
-
依托单位:
ASSESSMENT OF INSULIN SENSITIVITY BY TWO STEP CONSTANT GLUCOSE INFUSION
-
批准号:3742810
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:ABHIMANYU GARG
-
依托单位:
海外基金